Qube Research & Technologies (QRT)
LFCR icon

Qube Research & Technologies (QRT)’s Lifecore Biomedical LFCR Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$279K Buy
+75,097
New +$519K ﹤0.01% 2883
2025
Q4 		– Sell
-14,133
Closed -$104K – 3901
2025
Q3 		$104K Sell
14,133
-3,533
-20% -$26.7K ﹤0.01% 3056
2025
Q2 		$143K Sell
17,666
-37,741
-68% -$254K ﹤0.01% 2975
2025
Q1 		$390K Sell
55,407
-19,325
-26% -$120K ﹤0.01% 2638
2024
Q4 		$555K Sell
74,732
-19,644
-21% -$125K ﹤0.01% 2421
2024
Q3 		$465K Buy
94,376
+12,904
+16% +$67.4K ﹤0.01% 2297
2024
Q2 		$418K Sell
81,472
-61,807
-43% -$366K ﹤0.01% 2204
2024
Q1 		$761K Sell
143,279
-4,147
-3% -$29.7K ﹤0.01% 2305
2023
Q4 		$913K Buy
147,426
+120,095
+439% +$834K ﹤0.01% 1976
2023
Q3 		$206K Sell
27,331
-580
-2% -$5.3K ﹤0.01% 2396
2023
Q2 		$270K Buy
+27,911
New +$170K ﹤0.01% 1686

Other funds holding LFCR

2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GC
Grizzlyrock Capital Chicago, Illinois $126M AUM 11.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Qube Research & Technologies (QRT)'s LFCR Position: Q1 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Lifecore Biomedical (LFCR) in Q1 2026: 75,097 shares worth $279K. The stake represents ﹤0.01% of the portfolio and ranks #2883 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in LFCR as recently as Q3 2025.

Qube Research & Technologies (QRT) first reported a position in LFCR in Q2 2023 and has held it in 11 quarters since. The position peaked at $913K in Q4 2023. 105 funds tracked by Wall St. Rank hold LFCR as of Q1 2026.

  • Qube Research & Technologies (QRT) held 75,097 shares of Lifecore Biomedical worth $279K as of Q1 2026.
  • Lifecore Biomedical was a new Qube Research & Technologies (QRT) position in Q1 2026.
  • Lifecore Biomedical made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #2883 holding.
  • Qube Research & Technologies (QRT) first reported a position in Lifecore Biomedical in Q2 2023 and has held it in 11 quarters since.
  • Qube Research & Technologies (QRT)'s Lifecore Biomedical position peaked at $913K in Q4 2023.
  • 105 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.